annual total liabilities:
$7.88B+$1.58B(+25.13%)Summary
- As of today (May 21, 2025), RPRX annual total liabilities is $7.88 billion, with the most recent change of +$1.58 billion (+25.13%) on December 31, 2024.
- During the last 3 years, RPRX annual total liabilities has risen by +$613.03 million (+8.44%).
- RPRX annual total liabilities is now at all-time high.
Performance
RPRX Total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly total liabilities:
$7.82B-$60.75M(-0.77%)Summary
- As of today (May 21, 2025), RPRX quarterly total liabilities is $7.82 billion, with the most recent change of -$60.75 million (-0.77%) on March 31, 2025.
- Over the past year, RPRX quarterly total liabilities has increased by +$1.55 billion (+24.77%).
- RPRX quarterly total liabilities is now -1.08% below its all-time high of $7.90 billion, reached on June 30, 2024.
Performance
RPRX quarterly total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
RPRX Total liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +25.1% | +24.8% |
| 3 y3 years | +8.4% | +8.1% |
| 5 y5 years | +24.9% | +25.9% |
RPRX Total liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +25.1% | -1.1% | +24.8% |
| 5 y | 5-year | at high | +28.7% | -1.1% | +28.7% |
| alltime | all time | at high | +28.7% | -1.1% | +28.7% |
RPRX Total liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $7.82B(-0.8%) |
| Dec 2024 | $7.88B(+25.1%) | $7.88B(+1.2%) |
| Sep 2024 | - | $7.78B(-1.5%) |
| Jun 2024 | - | $7.90B(+26.1%) |
| Mar 2024 | - | $6.27B(-0.5%) |
| Dec 2023 | $6.30B(-13.6%) | $6.30B(+0.4%) |
| Sep 2023 | - | $6.27B(-14.2%) |
| Jun 2023 | - | $7.31B(+0.8%) |
| Mar 2023 | - | $7.25B(-0.5%) |
| Dec 2022 | $7.29B | $7.29B(+0.4%) |
| Sep 2022 | - | $7.26B(-1.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $7.33B(+1.3%) |
| Mar 2022 | - | $7.24B(-0.4%) |
| Dec 2021 | $7.27B(+18.7%) | $7.27B(-1.1%) |
| Sep 2021 | - | $7.35B(+20.2%) |
| Jun 2021 | - | $6.11B(+0.5%) |
| Mar 2021 | - | $6.08B(-0.8%) |
| Dec 2020 | $6.12B(-2.9%) | $6.12B(-1.1%) |
| Sep 2020 | - | $6.19B(-1.6%) |
| Jun 2020 | - | $6.29B(+1.3%) |
| Mar 2020 | - | $6.21B(-1.6%) |
| Dec 2019 | $6.31B(-7.5%) | $6.31B |
| Dec 2018 | $6.82B | - |
FAQ
- What is Royalty Pharma annual total liabilities?
- What is the all time high annual total liabilities for Royalty Pharma?
- What is Royalty Pharma annual total liabilities year-on-year change?
- What is Royalty Pharma quarterly total liabilities?
- What is the all time high quarterly total liabilities for Royalty Pharma?
- What is Royalty Pharma quarterly total liabilities year-on-year change?
What is Royalty Pharma annual total liabilities?
The current annual total liabilities of RPRX is $7.88B
What is the all time high annual total liabilities for Royalty Pharma?
Royalty Pharma all-time high annual total liabilities is $7.88B
What is Royalty Pharma annual total liabilities year-on-year change?
Over the past year, RPRX annual total liabilities has changed by +$1.58B (+25.13%)
What is Royalty Pharma quarterly total liabilities?
The current quarterly total liabilities of RPRX is $7.82B
What is the all time high quarterly total liabilities for Royalty Pharma?
Royalty Pharma all-time high quarterly total liabilities is $7.90B
What is Royalty Pharma quarterly total liabilities year-on-year change?
Over the past year, RPRX quarterly total liabilities has changed by +$1.55B (+24.77%)